Multifaceted activities of type I interferon are revealed by a receptor antagonist.
about
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesInsights into cytokine-receptor interactions from cytokine engineeringReceptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signalingExpansion of amphibian intronless interferons revises the paradigm for interferon evolution and functional diversityInterferons and viruses: an evolutionary arms race of molecular interactionsCytokine Activation by Antibody Fragments Targeted to Cytokine-Receptor Signaling Complexes.Extraordinary effects of unnatural pairingsType I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.New insights into type I interferon and the immunopathogenesis of persistent viral infections.Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps.Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers.Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.Spatiotemporal control of interferon-induced JAK/STAT signalling and gene transcription by the retromer complex.Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs.Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain.IFNAR2-dependent gene expression profile induced by IFN-α in Pteropus alecto bat cells and impact of IFNAR2 knockout on virus infection.A hot spot on interferon α/β receptor subunit 1 (IFNAR1) underpins its interaction with interferon-β and dictates signaling.Fine Tuning of a Type 1 Interferon Antagonist.Human pDCs display sex-specific differences in type I interferon subtypes and interferon α/β receptor expression.The molecular basis for differential type I interferon signaling.Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection.The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity.Dynamic Modulation of Binding Affinity as a Mechanism for Regulating Interferon Signaling.Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling.Mapping Determinants of Cytokine Signaling via Protein EngineeringType I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication
P2860
Q21131160-D45632D3-5372-4CCF-9A48-1802FC90646CQ26852703-D50E30E6-6D72-4E45-BC48-36F55702FE8BQ27310374-B8A96FAF-5882-4E5B-B743-68F408FFC858Q27469006-1E15D4B8-5535-425C-8123-127E188DB1F7Q28083788-5728F990-7897-4F15-B9B1-5B4C777723D2Q30381154-F546839E-655B-4D56-95BE-D09633478B31Q33675627-C87655CB-F184-4413-953F-EA490FDD46DDQ35564886-83FC6516-ACE9-4786-A08A-904C3CCF049EQ35648751-B34BBDCB-E78D-44B7-9DB5-F4B6FF7BB921Q36028807-A3F9E80B-57C6-4E94-A17B-15246D51D85BQ36370053-8BBEA4CC-18C6-461B-9206-DF9A5625B89DQ36450748-77F7C22F-6838-48E1-ABE8-A8EE1586DE30Q37123447-86028EE5-6BEC-45C8-94AE-BBA75AA906A7Q37492886-14BFD054-8BCD-49C8-883F-2E8CD243BE2DQ37545050-7E0172E9-BD2C-4672-8824-FE3E58B14C10Q38378144-CFA6250C-256D-40CE-8B8A-5BB69F7F834EQ38644834-6CCF4F71-D504-40EE-A023-5447E06FE6CDQ38712385-86A14A95-4D08-43FC-ABE5-69DFA782276CQ38855055-F9EDA90E-AB93-4CF0-BB30-A71778AC1C6BQ39149760-AC9F7797-9A2C-4644-9871-78CE40CD6B95Q39176574-E85907ED-15DF-4A08-8F58-9513887D32CFQ40160105-7DC32F80-1176-4C21-96E1-B0DEAB88574EQ40280003-130CA45B-959A-4643-B9AE-CCC99F1452E7Q47565835-CA7DC797-DC81-4A0B-85BA-0618F5F04F10Q50963822-50EC6B5F-39F2-4E73-8D39-F8D7E0D63F35Q57490861-A0542ED5-247C-43DF-B00F-3439C2164FEBQ58704921-1973905F-7CFC-4856-A6CA-1D0629E40B1E
P2860
Multifaceted activities of type I interferon are revealed by a receptor antagonist.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Multifaceted activities of type I interferon are revealed by a receptor antagonist.
@ast
Multifaceted activities of type I interferon are revealed by a receptor antagonist.
@en
type
label
Multifaceted activities of type I interferon are revealed by a receptor antagonist.
@ast
Multifaceted activities of type I interferon are revealed by a receptor antagonist.
@en
prefLabel
Multifaceted activities of type I interferon are revealed by a receptor antagonist.
@ast
Multifaceted activities of type I interferon are revealed by a receptor antagonist.
@en
P2093
P2860
P1433
P1476
Multifaceted activities of type I interferon are revealed by a receptor antagonist.
@en
P2093
Alberto Giovanni Busetto
Charles M Rice
Doron Levin
Ganit Yarden
Gideon Schreiber
Hans-Heinrich Hoffmann
Nanaocha Sharma
Ohad Manor
William M Schneider
P2860
P356
10.1126/SCISIGNAL.2004998
P577
2014-05-27T00:00:00Z